Aster DM Healthcare Adjusts Financial Evaluation Amid Mixed Performance Indicators

Aster DM Healthcare has recently undergone an adjustment in its evaluation, reflecting notable shifts in its financial metrics. The company reported flat financial performance for the quarter ending September 2025, with key indicators showing significant figures. Operating profit to interest reached a high of 8.12 times, while net sales peaked at Rs 1,197.21 crore. Additionally, the company recorded its highest PBDIT at Rs 249.84 crore and a PAT of Rs 110.26 crore, contributing to a revised score that indicates a change in its financial grade. However, the company faces challenges, as evidenced by a decline in PAT over the latest six months, which stood at Rs 198.79 crore, reflecting a substantial decrease. The debtors turnover ratio also reached a low of 1.38 times, indicating potential liquidity concerns. Despite these challenges, Aster DM Healthcare has demonstrated strong market performance, outperforming the BSE500 over various time frames, including a 59.15% return over the past year. The company’s management efficiency is highlighted by a robust ROE of 17.18%, although long-term growth remains a concern with negative sales growth over the past five years. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.